SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
24-Aug-23 5:58 PM View: | Rivard Paul Chief Legal Officer | Mymd Pharmaceuticals, Inc. (MYMD) | 24-Aug-23 | Private Purchase | 150,000 | $1.11 | $166,500.00 | 60% 250.0K to 400.0K | |
18-Aug-23 4:21 PM View: | Rivard Paul Chief Legal Officer | Mymd Pharmaceuticals, Inc. (MYMD) | 17-Aug-23 | Private Purchase | 25,000 | $1.12 | $28,080.00 | 11% 225.0K to 250.0K | |
08-Dec-22 8:24 PM View: | Rivard Paul EVP of Operations, GC | Mymd Pharmaceuticals, Inc. (MYMD) | 08-Dec-22 | Private Purchase | 10,000 | $1.53 | $15,300.00 | 5% 215.0K to 225.0K | |
29-Nov-21 12:46 PM View: | Silverman Joshua Director | Mymd Pharmaceuticals, Inc. (MYMD) | 26-Nov-21 | Market Purchase | 5,000 | $7.55 | $37,771.50 | 6% 83.78K to 88.78K | |
29-Nov-21 12:46 PM View: | Silverman Joshua Director | Mymd Pharmaceuticals, Inc. (MYMD) | 24-Nov-21 | Private Purchase | 10,000 | $6.56 | $65,586.20 | 14% 73.78K to 83.78K | |
24-Nov-21 12:56 PM View: | Rivard Paul EVP of Operations, GC | Mymd Pharmaceuticals, Inc. (MYMD) | 23-Nov-21 | Market Purchase | 15,000 | $6.03 | $90,450.00 | 8% 200.0K to 215.0K | < 1% |
20-Apr-21 9:32 PM View: | White Billy Joe Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Payment of Exercise | 38,325 | $4.94 | $189,326.00 | (35%) 109.5K to 71.17K | |
21-Apr-21 5:55 PM View: | Schreiber Christopher C Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Payment of Exercise | 46,113 | $4.94 | $227,798.00 | (34%) 134.35K to 88.24K | |
20-Apr-21 9:37 PM View: | Schroeder Robert C Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Option Exercise | 43,930 | -- | -- | 100% 0 to 43.93K | |
20-Apr-21 9:35 PM View: | Silverman Joshua Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Payment of Exercise | 38,325 | $4.94 | $189,326.00 | (35%) 109.5K to 71.17K | |
20-Apr-21 9:32 PM View: | White Billy Joe Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Option Exercise | 109,500 | -- | -- | 100% 0 to 109.5K | |
21-Apr-21 5:55 PM View: | Schreiber Christopher C Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Option Exercise | 131,750 | -- | -- | 5065% 2.6K to 134.35K | |
21-Apr-21 4:53 PM View: | Chapman Christopher C Jr President, Chief Med. Officer Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Grant | 96,475 | -- | -- | 100% 0 to 96.47K | |
20-Apr-21 9:37 PM View: | Schroeder Robert C Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Payment of Exercise | 14,694 | $4.94 | $72,588.40 | (33%) 43.93K to 29.24K | |
20-Apr-21 9:35 PM View: | Silverman Joshua Director | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Apr-21 | Option Exercise | 109,500 | -- | -- | 100% 0 to 109.5K | |
03-Mar-20 2:55 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 28-Feb-20 | Market Sale | 638 | $2.81 | $1,792.78 | (< 1%) 240.94K to 240.31K | 27% |
27-Feb-20 4:06 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 27-Feb-20 | Market Sale | 15,300 | $2.72 | $41,616.00 | (3%) 512.49K to 497.19K | 24% |
27-Feb-20 4:06 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 25-Feb-20 | Market Sale | 13,000 | $2.92 | $37,960.00 | (2%) 525.49K to 512.49K | 29% |
03-Jan-20 7:10 PM View: | White Billy Joe Director | Mymd Pharmaceuticals, Inc. (MYMD) | 01-Jan-20 | Option Exercise | 5,201 | -- | -- | 100% 0 to 5.2K | |
03-Jan-20 7:11 PM View: | Schreiber Christopher C Executive Chairman Director | Mymd Pharmaceuticals, Inc. (MYMD) | 01-Jan-20 | Option Exercise | 5,201 | -- | -- | 100% 0 to 5.2K | |
03-Jan-20 7:07 PM View: | Silverman Joshua Director | Mymd Pharmaceuticals, Inc. (MYMD) | 01-Jan-20 | Option Exercise | 5,201 | -- | -- | 100% 0 to 5.2K | |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 20-Dec-19 | Market Purchase | 8,000 | $3.02 | $24,160.00 | 2% 365.26K to 373.26K | (32%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 19-Dec-19 | Market Purchase | 2,700 | $3.08 | $8,316.00 | < 1% 362.56K to 365.26K | (34%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 18-Dec-19 | Market Purchase | 7,500 | $3.07 | $23,025.00 | 2% 354.56K to 362.06K | (33%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 17-Dec-19 | Market Purchase | 3,000 | $3.03 | $9,090.00 | < 1% 352.06K to 355.06K | (33%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 16-Dec-19 | Market Purchase | 5,000 | $3.07 | $15,350.00 | 1% 347.06K to 352.06K | (33%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 13-Dec-19 | Market Purchase | 6,000 | $3.02 | $18,120.00 | 2% 341.06K to 347.06K | (32%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 12-Dec-19 | Market Purchase | 20,600 | $2.98 | $61,388.00 | 6% 320.46K to 341.06K | (32%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 11-Dec-19 | Market Purchase | 32,425 | $3.09 | $100,217.00 | 11% 288.04K to 320.46K | (34%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 10-Dec-19 | Market Purchase | 30,000 | $2.97 | $89,100.00 | 12% 258.04K to 288.04K | (31%) |
07-Jan-20 5:32 PM View: | Hudson Bay Capital Manageme... 10% Owner | Mymd Pharmaceuticals, Inc. (MYMD) | 09-Dec-19 | Market Purchase | 69,353 | $2.98 | $206,785.00 | 37% 188.68K to 258.04K | (32%) |
03-Oct-19 4:05 PM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 02-Oct-19 | Grant | 3,750 | $0.42 | $1,560.00 | 9% 41.25K to 45.0K | (80%) |
04-Sep-19 8:49 PM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 30-Aug-19 | Grant | 3,750 | $0.43 | $1,612.50 | 10% 37.5K to 41.25K | (80%) |
01-Aug-19 9:22 AM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 31-Jul-19 | Grant | 3,750 | $0.42 | $1,575.00 | 11% 33.75K to 37.5K | (79%) |
28-Jun-19 6:05 PM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 28-Jun-19 | Grant | 3,750 | $0.45 | $1,695.00 | 12% 30.0K to 33.75K | (81%) |
30-May-19 4:05 PM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 24-May-19 | Grant | 7,500 | $0.65 | $4,875.00 | 33% 22.5K to 30.0K | (86%) |
29-Mar-19 7:54 PM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 29-Mar-19 | Grant | 15,000 | $0.97 | $14,550.00 | 200% 7.5K to 22.5K | (91%) |
02-Jan-19 5:00 PM View: | Yeaton Howard CEO, CFO | Mymd Pharmaceuticals, Inc. (MYMD) | 28-Dec-18 | Grant | 7,500 | $1.27 | $9,525.00 | 100% 0 to 7.5K | (93%) |
24-Oct-17 4:54 PM View: | Rauch Gary M VP - Finance, Treasurer | Mymd Pharmaceuticals, Inc. (MYMD) | 17-Oct-17 | Grant | 36,277 | $0.88 | $31,923.80 | 132% 27.5K to 63.78K | (99%) |
24-Oct-17 4:50 PM View: | Gormally John J Chief Executive Officer Director | Mymd Pharmaceuticals, Inc. (MYMD) | 17-Oct-17 | Gift | 150,000 | $0.88 | $132,000.00 | 500% 30.0K to 180.0K | (99%) |
13-Feb-17 10:00 PM View: | Knox Brandon Thomas Director | Mymd Pharmaceuticals, Inc. (MYMD) | 02-Sep-16 | Gift | 13,750 | -- | -- | (10%) 138.08K to 124.33K | |
14-Jun-16 7:00 AM View: | Gormally John J Chief Executive Officer Director | Mymd Pharmaceuticals, Inc. (MYMD) | 08-Jun-16 | Gift | 27,500 | $1.99 | $54,725.00 | 1100% 2.5K to 30.0K | (100%) |
24-May-16 5:57 PM View: | Gormally John J Chief Executive Officer | Mymd Pharmaceuticals, Inc. (MYMD) | 24-May-16 | Market Purchase | 2,500 | $2.23 | $5,566.86 | 100% 0 to 2.5K | (100%) |
06-Jan-16 6:02 AM View: | Akers Raymond Francis Jr Executive Chairman, Secretary Director | Mymd Pharmaceuticals, Inc. (MYMD) | 05-Jan-16 | Market Purchase | 2,100 | $1.34 | $2,814.00 | 3% 70.0K to 72.1K | (99%) |
31-Dec-15 12:06 PM View: | Bokhari Raza Director | Mymd Pharmaceuticals, Inc. (MYMD) | 30-Dec-15 | Grant | 32,083 | -- | -- | 100% 0 to 32.08K | |
31-Dec-15 3:43 PM View: | Knox Brandon Thomas Director | Mymd Pharmaceuticals, Inc. (MYMD) | 30-Dec-15 | Grant | 55,000 | -- | -- | 66% 83.08K to 138.08K | |
31-Dec-15 12:10 PM View: | Andrews Robert E Director | Mymd Pharmaceuticals, Inc. (MYMD) | 30-Dec-15 | Grant | 48,125 | -- | -- | 100% 0 to 48.13K | |
05-Jan-16 2:03 PM View: | Knox Thomas J Director | Mymd Pharmaceuticals, Inc. (MYMD) | 30-Dec-15 | Grant | 70,000 | -- | -- | 17% 408.15K to 478.15K | |
31-Dec-15 12:12 PM View: | Rauch Gary M VP - Finance, Treasurer | Mymd Pharmaceuticals, Inc. (MYMD) | 30-Dec-15 | Grant | 22,500 | -- | -- | 450% 5.0K to 27.5K | |
14-Dec-15 4:16 PM View: | Rauch Gary M VP - Finance, Treasurer | Mymd Pharmaceuticals, Inc. (MYMD) | 11-Dec-15 | Market Purchase | 3,500 | $1.50 | $5,250.00 | 233% 1.5K to 5.0K | (99%) |